For many years, exercise was viewed primarily as a way to improve fitness and overall health. Today, researchers are discovering that physical activity may play a much larger role in cancer care. A growing body of evidence suggests that regular exercise can improve quality of life, reduce treatment-related side effects, and may even help people live longer after a cancer diagnosis.
A major new systematic review and meta-analysis of randomized controlled trials adds to this evidence. The study found that structured physical activity programs were associated with a significant reduction in all-cause mortality among people with cancer, highlighting exercise as an important part of cancer survivorship and long-term health.
Why Researchers Are Studying Exercise in Cancer Care
Cancer treatment has improved dramatically over the past few decades. As a result, more people are living longer after their diagnosis. This has led researchers to focus not only on treating cancer but also on improving long-term outcomes and quality of life.
Physical activity has become an area of particular interest because it may influence several factors linked to cancer outcomes, including:
- Physical function
- Cardiovascular health
- Inflammation
- Muscle strength
- Body composition
- Mental well-being
Researchers have increasingly asked whether exercise could do more than help patients feel better—whether it could actually improve survival.
What the Research Found
The review analyzed randomized controlled trials involving cancer patients who participated in structured physical activity programs.
Researchers found that patients assigned to exercise interventions experienced a significant reduction in all-cause mortality compared with those receiving usual care.
These findings are particularly important because randomized controlled trials are considered one of the strongest forms of medical evidence. Unlike observational studies, they help determine whether an intervention is directly contributing to the outcome being measured.
The results suggest that physical activity may have a meaningful impact on long-term survival for people living with and beyond cancer.
How Exercise May Help Cancer Survivors
While researchers are still studying the exact mechanisms involved, several explanations may help explain the benefits.
Regular physical activity can:
- Improve heart and lung function
- Reduce treatment-related fatigue
- Help maintain muscle mass
- Improve insulin sensitivity
- Reduce chronic inflammation
- Support mental health
Exercise may also help survivors stay independent and physically active as they age, reducing the risk of other health conditions that can affect overall survival.
The benefits appear to extend beyond any single cancer type, suggesting that physical activity may support overall health in ways that complement traditional cancer treatments.
What Type of Physical Activity Is Best?
One of the encouraging findings from cancer exercise research is that benefits are not limited to intense athletic training.
Many successful programs included:
- Walking
- Aerobic exercise
- Resistance training
- Strength-building activities
- Structured fitness programs
The goal is not necessarily to become an athlete but to remain consistently active.
Researchers emphasize that exercise plans should be tailored to an individual’s health status, treatment history, and physical abilities.
A New Era in Cancer Survivorship
The growing evidence supporting physical activity is changing how experts think about cancer care.
Exercise is increasingly being viewed as an important component of survivorship rather than simply a lifestyle recommendation. Some experts have even begun referring to physical activity as a form of supportive medicine because of its broad effects on health and recovery.
While exercise is not a replacement for cancer treatment, this research suggests it may be one of the most powerful tools available to help improve long-term outcomes after a cancer diagnosis.
Source
Zhang X, et al. Physical activity reduces all-cause mortality in patients with cancer: a systematic review and meta-analysis of randomized controlled trials. Cancer Treat Rev. 2026. Accessed by: https://www.cancertreatmentreviews.com/article/S0305-7372(26)00036-8/fulltext
